Great Point Partners LLC Kura Oncology, Inc. Transaction History

Great Point Partners LLC

$216 Million
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $7.71 Million - $10.9 Million	-500,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $10.4 Million - $14.9 Million	500,000 New	500,000 $10.4 Million
Q2 2020 Aug 14, 2020	SELL	$7.95 - $18.81 $1.43 Million - $3.38 Million	-179,700 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$6.45 - $14.04 $4.35 Million - $9.46 Million	-674,077 Reduced 78.95%	179,700 $1.79 Million
Q4 2019 Feb 14, 2020	SELL	$12.97 - $15.94 $29 Million - $35.6 Million	-2,232,276 Reduced 72.33%	853,777 $11.7 Million
Q3 2019 Nov 15, 2019	BUY	$14.75 - $20.87 $564,231 - $798,340	38,253 Added 1.26%	3,086,053 $46.8 Million
Q2 2019 Aug 14, 2019	BUY	$14.71 - $19.79 $5.92 Million - $7.97 Million	402,700 Added 15.22%	3,047,800 $0
Q1 2019 May 14, 2019	SELL	$13.73 - $16.87 $1.71 Million - $2.1 Million	-124,427 Reduced 4.49%	2,645,100 $43.9 Million
Q4 2018 Feb 15, 2019	BUY	$10.6 - $17.49 $6.89 Million - $11.4 Million	650,421 Added 30.69%	2,769,527 $38.9 Million
Q3 2018 Nov 14, 2018	SELL	$16.65 - $21.85 $8.46 Million - $11.1 Million	-508,004 Reduced 19.34%	2,119,106 $37.1 Million
Q2 2018 Aug 14, 2018	BUY	$14.8 - $18.8 $3.64 Million - $4.63 Million	246,264 Added 10.34%	2,627,110 $47.8 Million
Q1 2018 May 14, 2018	BUY	$14.5 - $23.4 $2.66 Million - $4.3 Million	183,563 Added 8.35%	2,380,846 $0
Q4 2017 Feb 14, 2018	BUY	$13.5 - $16.65 $6.03 Million - $7.43 Million	446,396 Added 25.5%	2,197,283 $33.6 Million
Q3 2017 Nov 14, 2017	BUY	$6.05 - $14.95 $10.6 Million - $26.2 Million	1,750,887	1,750,887 $26.2 Million

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

Suvretta Capital Management, LLC New York, NY

7.65M
Shares

$69 Million
5.88% of portfolio
Black Rock Inc. New York, NY

6.97M
Shares

$62.8 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.81M
Shares

$52.3 Million
4.92% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

5.41M
Shares

$48.8 Million
1.97% of portfolio
Paradigm Biocapital Advisors LP New York, NY

4.33M
Shares

$39 Million
3.05% of portfolio

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Account